<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32065260</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>Synaptotagmin 13 is neuroprotective across motor neuron diseases.</ArticleTitle><Pagination><StartPage>837</StartPage><EndPage>853</EndPage><MedlinePgn>837-853</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-020-02133-x</ELocationID><Abstract><AbstractText>In amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), spinal and lower brainstem motor neurons degenerate, but some motor neuron subtypes are spared, including oculomotor neurons (OMNs). The mechanisms responsible for this selective degeneration are largely unknown, but the molecular signatures of resistant and vulnerable motor neurons are distinct and offer clues to neuronal resilience and susceptibility. Here, we demonstrate that healthy OMNs preferentially express Synaptotagmin 13 (SYT13) compared to spinal motor neurons. In end-stage ALS patients, SYT13 is enriched in both OMNs and the remaining relatively resilient spinal motor neurons compared to controls. Overexpression of SYT13 in ALS and SMA patient motor neurons in vitro improves their survival and increases axon lengths. Gene therapy with Syt13 prolongs the lifespan of ALS mice by 14% and SMA mice by 50% by preserving motor neurons and delaying muscle denervation. SYT13 decreases endoplasmic reticulum stress and apoptosis of motor neurons, both in vitro and in vivo. Thus, SYT13 is a resilience factor that can protect motor neurons and a candidate therapeutic target across motor neuron diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nizzardo</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taiana</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguila Benitez</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Biomedicum D7, Karolinska Institutet, Solna v. 9, 171 77, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nijssen</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Biomedicum D7, Karolinska Institutet, Solna v. 9, 171 77, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allodi</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Biomedicum D7, Karolinska Institutet, Solna v. 9, 171 77, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melzi</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bresolin</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comi</LastName><ForeName>G P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neuromuscular and Rare Diseases Unit, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hedlund</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Biomedicum D7, Karolinska Institutet, Solna v. 9, 171 77, Stockholm, Sweden. eva.hedlund@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corti</LastName><ForeName>S</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5425-969X</Identifier><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Milan, Italy. stefania.corti@unimi.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Via Francesco Sforza 35, 20122, Milan, Italy. stefania.corti@unimi.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494271">SYT13 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>134193-27-4</RegistryNumber><NameOfSubstance UI="D050857">Synaptotagmins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurol. 2020 Apr;16(4):186</RefSource><PMID Version="1">32132701</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050857" MajorTopicYN="N">Synaptotagmins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32065260</ArticleId><ArticleId IdType="pmc">PMC7181443</ArticleId><ArticleId IdType="doi">10.1007/s00401-020-02133-x</ArticleId><ArticleId IdType="pii">10.1007/s00401-020-02133-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol. 1994;36:846&#x2013;858. doi: 10.1002/ana.410360608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410360608</ArticleId><ArticleId IdType="pubmed">7998770</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi I, Comley L, Nichterwitz S, Nizzardo M, Simone C, Benitez JA, et al. Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS. Sci Rep. 2016;6:25960. doi: 10.1038/srep25960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25960</ArticleId><ArticleId IdType="pmc">PMC4867585</ArticleId><ArticleId IdType="pubmed">27180807</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi I, Nijssen J, Benitez JA, Schweingruber C, Fuchs A, Bonvicini G, et al. modeling motor neuron resilience in als using stem cells. Stem Cell Rep. 2019;12:1329&#x2013;1341. doi: 10.1016/j.stemcr.2019.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2019.04.009</ArticleId><ArticleId IdType="pmc">PMC6565614</ArticleId><ArticleId IdType="pubmed">31080111</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi MA, Dahlberg PD, Mazuski RJ, Davis HC, Otto JP, Engel GS. Optical resonance imaging: an optical analog to MRI with sub-diffraction-limited capabilities. ACS Photon. 2016;3:2445&#x2013;2452. doi: 10.1021/acsphotonics.6b00694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsphotonics.6b00694</ArticleId><ArticleId IdType="pmc">PMC5403159</ArticleId><ArticleId IdType="pubmed">28451625</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E, Catania MV, Geurts J, Yankaya B, Troost D. Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience. 2001;105:509&#x2013;520. doi: 10.1016/s0306-4522(01)00181-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0306-4522(01)00181-6</ArticleId><ArticleId IdType="pubmed">11672616</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A, Ning K, Heath PR, Wood E, Kirby J, Fusi N, et al. Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol. 2013;125:95&#x2013;109. doi: 10.1007/s00401-012-1058-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1058-5</ArticleId><ArticleId IdType="pmc">PMC3535376</ArticleId><ArticleId IdType="pubmed">23143228</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotherton TE, Li Y, Cooper D, Gearing M, Julien JP, Rothstein JD, et al. Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS. PNAS. 2012;109:5505&#x2013;5510. doi: 10.1073/pnas.1115009109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115009109</ArticleId><ArticleId IdType="pmc">PMC3325721</ArticleId><ArticleId IdType="pubmed">22431618</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucchia M, Ramirez A, Parente V, Simone C, Nizzardo M, Magri F, et al. Therapeutic development in amyotrophic lateral sclerosis. Clin Ther. 2015;37:668&#x2013;680. doi: 10.1016/j.clinthera.2014.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2014.12.020</ArticleId><ArticleId IdType="pubmed">25666449</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley L, Allodi I, Nichterwitz S, Nizzardo M, Simone C, Corti S, et al. Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS. Neuroscience. 2015;291:216&#x2013;229. doi: 10.1016/j.neuroscience.2015.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.02.013</ArticleId><ArticleId IdType="pubmed">25697826</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley LH, Nijssen J, Frost-Nylen J, Hedlund E. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology. J Comp Neurol. 2016;524:1424&#x2013;1442. doi: 10.1002/cne.23917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23917</ArticleId><ArticleId IdType="pmc">PMC5063101</ArticleId><ArticleId IdType="pubmed">26502195</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti S, Nizzardo M, Simone C, Falcone M, Donadoni C, Salani S, et al. Direct reprogramming of human astrocytes into neural stem cells and neurons. Exp Cell Res. 2012;318:1528&#x2013;1541. doi: 10.1016/j.yexcr.2012.02.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2012.02.040</ArticleId><ArticleId IdType="pmc">PMC3405531</ArticleId><ArticleId IdType="pubmed">22426197</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti S, Nizzardo M, Simone C, Falcone M, Nardini M, Ronchi D, et al. Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci Transl Med. 2012;4:165&#x2013;162. doi: 10.1126/scitranslmed.3004108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004108</ArticleId><ArticleId IdType="pmc">PMC4722730</ArticleId><ArticleId IdType="pubmed">23253609</ArticleId></ArticleIdList></Reference><Reference><Citation>d'Errico P, Boido M, Piras A, Valsecchi V, De Amicis E, Locatelli D, et al. Selective vulnerability of spinal and cortical motor neuron subpopulations in delta7 SMA mice. PLoS ONE. 2013;8:e82654. doi: 10.1371/journal.pone.0082654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082654</ArticleId><ArticleId IdType="pmc">PMC3855775</ArticleId><ArticleId IdType="pubmed">24324819</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R, Scaber J, Ababneh N, Lalic T, Weir G, Christian H, et al. C9orf72 hexanucleotide expansions are associated with altered endoplasmic reticulum calcium homeostasis and stress granule formation in induced pluripotent stem cell-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal dementia. Stem cells. 2016;34:2063&#x2013;2078. doi: 10.1002/stem.2388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2388</ArticleId><ArticleId IdType="pmc">PMC4979662</ArticleId><ArticleId IdType="pubmed">27097283</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci. 2007;10:608&#x2013;614. doi: 10.1038/nn1885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1885</ArticleId><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, Vidensky S, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80:415&#x2013;428. doi: 10.1016/j.neuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert AD, Yu J, Rose FF, Jr, Mattis VB, Lorson CL, Thomson JA, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2009;457:277&#x2013;280. doi: 10.1038/nature07677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07677</ArticleId><ArticleId IdType="pmc">PMC2659408</ArticleId><ArticleId IdType="pubmed">19098894</ArticleId></ArticleIdList></Reference><Reference><Citation>Faravelli I, Nizzardo M, Comi GP, Corti S. Spinal muscular atrophy&#x2013;recent therapeutic advances for an old challenge. Nat Rev Neurol. 2015;11:351&#x2013;359. doi: 10.1038/nrneurol.2015.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.77</ArticleId><ArticleId IdType="pubmed">25986506</ArticleId></ArticleIdList></Reference><Reference><Citation>Faravelli I, Riboldi G, Nizzardo M, Simone C, Zanetta C, Bresolin N, et al. Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation. Cell Mol Life Sci CMLS. 2014;71:3257&#x2013;3268. doi: 10.1007/s00018-014-1613-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-014-1613-4</ArticleId><ArticleId IdType="pubmed">24699704</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda M, Mikoshiba K. Characterization of KIAA1427 protein as an atypical synaptotagmin (Syt XIII) Biochem J. 2001;354:249&#x2013;257. doi: 10.1042/0264-6021:3540249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/0264-6021:3540249</ArticleId><ArticleId IdType="pmc">PMC1221650</ArticleId><ArticleId IdType="pubmed">11171101</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda M, Mikoshiba K. Synaptotagmin-like protein 1&#x2013;3: a novel family of C-terminal-type tandem C2 proteins. Biochem Biophys Res Commun. 2001;281:1226&#x2013;1233. doi: 10.1006/bbrc.2001.4512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2001.4512</ArticleId><ArticleId IdType="pubmed">11243866</ArticleId></ArticleIdList></Reference><Reference><Citation>Gizzi M, DiRocco A, Sivak M, Cohen B. Ocular motor function in motor neuron disease. Neurology. 1992;42:1037&#x2013;1046. doi: 10.1212/wnl.42.5.1037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.42.5.1037</ArticleId><ArticleId IdType="pubmed">1579227</ArticleId></ArticleIdList></Reference><Reference><Citation>Govoni A, Gagliardi D, Comi GP, Corti S. Time Is Motor Neuron: Therapeutic Window and Its Correlation with Pathogenetic Mechanisms in Spinal Muscular Atrophy. Mol Neurobiol. 2018;55:6307&#x2013;6318. doi: 10.1007/s12035-017-0831-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0831-9</ArticleId><ArticleId IdType="pubmed">29294245</ArticleId></ArticleIdList></Reference><Reference><Citation>Greif KF, Asabere N, Lutz GJ, Gallo G. Synaptotagmin-1 promotes the formation of axonal filopodia and branches along the developing axons of forebrain neurons. Dev Neurobiol. 2013;73:27&#x2013;44. doi: 10.1002/dneu.22033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.22033</ArticleId><ArticleId IdType="pubmed">22589224</ArticleId></ArticleIdList></Reference><Reference><Citation>Groenendyk J, Michalak M. Endoplasmic reticulum quality control and apoptosis. Acta Biochim Pol. 2005;52:381&#x2013;395. doi: 10.18388/abp.2005_3451.</Citation><ArticleIdList><ArticleId IdType="doi">10.18388/abp.2005_3451</ArticleId><ArticleId IdType="pubmed">15933766</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedlund E, Karlsson M, Osborn T, Ludwig W, Isacson O. Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection. Brain. 2010;133:2313&#x2013;2330. doi: 10.1093/brain/awq167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq167</ArticleId><ArticleId IdType="pmc">PMC3139939</ArticleId><ArticleId IdType="pubmed">20826431</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedlund PB, Leopoldo M, Caccia S, Sarkisyan G, Fracasso C, Martelli G, et al. LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor. Neurosci Lett. 2010;481:12&#x2013;16. doi: 10.1016/j.neulet.2010.06.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2010.06.036</ArticleId><ArticleId IdType="pmc">PMC2910240</ArticleId><ArticleId IdType="pubmed">20600619</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata M, Hirano A. Sparing of the Onufrowicz nucleus in sacral anterior horn lesions. Ann Neurol. 1978;4:245&#x2013;249. doi: 10.1002/ana.410040309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410040309</ArticleId><ArticleId IdType="pubmed">718135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanning KC, Kaplan A, Henderson CE. Motor neuron diversity in development and disease. Annu Rev Neurosci. 2010;33:409&#x2013;440. doi: 10.1146/annurev.neuro.051508.135722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.051508.135722</ArticleId><ArticleId IdType="pubmed">20367447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A, Spiller KJ, Towne C, Kanning KC, Choe GT, Geber A, et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron. 2014;81:333&#x2013;348. doi: 10.1016/j.neuron.2013.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.009</ArticleId><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, Wainger BJ, et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14:781&#x2013;795. doi: 10.1016/j.stem.2014.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.03.004</ArticleId><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota M, Sakakihara Y, Uchiyama Y, Nara A, Nagata T, Nitta H, et al. New ocular movement detector system as a communication tool in ventilator-assisted Werdnig-Hoffmann disease. Dev Med Child Neurol. 2000;42:61&#x2013;64. doi: 10.1017/s0012162200000116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0012162200000116</ArticleId><ArticleId IdType="pubmed">10665977</ArticleId></ArticleIdList></Reference><Reference><Citation>Laslo P, Lipski J, Nicholson LF, Miles GB, Funk GD. Calcium binding proteins in motoneurons at low and high risk for degeneration in ALS. NeuroReport. 2000;11:3305&#x2013;3308. doi: 10.1097/00001756-200010200-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200010200-00009</ArticleId><ArticleId IdType="pubmed">11059892</ArticleId></ArticleIdList></Reference><Reference><Citation>Le TT, Pham LT, Butchbach ME, Zhang HL, Monani UR, Coovert DD, et al. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet. 2005;14:845&#x2013;857. doi: 10.1093/hmg/ddi078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi078</ArticleId><ArticleId IdType="pubmed">15703193</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannen T. Considerations on the motor neuron specificity of the lesions of amyotrophic lateral sclerosis. Nippon Rinsho. 1977;35:4051&#x2013;4054.</Citation><ArticleIdList><ArticleId IdType="pubmed">599685</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto MC, Muotri AR, Mu Y, Smith AM, Cezar GG, Gage FH. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell. 2008;3:649&#x2013;657. doi: 10.1016/j.stem.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.10.001</ArticleId><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Matus S, Valenzuela V, Medinas DB, Hetz C. ER dysfunction and protein folding stress in ALS. Int J Cell Biol. 2013;2013:674751. doi: 10.1155/2013/674751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/674751</ArticleId><ArticleId IdType="pmc">PMC3845333</ArticleId><ArticleId IdType="pubmed">24324498</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y, Come J, Piskorowski RA, Salah-Mohellibi N, Chevaleyre V, Peschanski M, et al. Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat Biotechnol. 2015;33:89&#x2013;96. doi: 10.1038/nbt.3049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3049</ArticleId><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng SY, Soh BS, Rodriguez-Muela N, Hendrickson DG, Price F, Rinn JL, et al. Genome-wide RNA-seq of human motor neurons implicates selective ER stress activation in spinal muscular atrophy. Cell Stem Cell. 2015;17:569&#x2013;584. doi: 10.1016/j.stem.2015.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2015.08.003</ArticleId><ArticleId IdType="pmc">PMC4839185</ArticleId><ArticleId IdType="pubmed">26321202</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichterwitz S, Benitez JA, Hoogstraaten R, Deng Q, Hedlund E. LCM-Seq: a method for spatial transcriptomic profiling using laser capture microdissection coupled with PolyA-Based RNA sequencing. Methods Mol Biol. 2018;1649:95&#x2013;110. doi: 10.1007/978-1-4939-7213-5_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7213-5_6</ArticleId><ArticleId IdType="pubmed">29130192</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichterwitz S, Chen G, Aguila Benitez J, Yilmaz M, Storvall H, Cao M, et al. Laser capture microscopy coupled with Smart-seq2 for precise spatial transcriptomic profiling. Nat Commun. 2016;7:12139. doi: 10.1038/ncomms12139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12139</ArticleId><ArticleId IdType="pmc">PMC4941116</ArticleId><ArticleId IdType="pubmed">27387371</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizzardo M, Bucchia M, Ramirez A, Trombetta E, Bresolin N, Comi GP, et al. iPSC-derived LewisX+CXCR4+beta1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models. Hum Mol Genet. 2016;25:3152&#x2013;3163. doi: 10.1093/hmg/ddw163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw163</ArticleId><ArticleId IdType="pubmed">27270413</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizzardo M, Simone C, Dametti S, Salani S, Ulzi G, Pagliarani S, et al. Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches. Sci Rep. 2015;5:11746. doi: 10.1038/srep11746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11746</ArticleId><ArticleId IdType="pmc">PMC4485234</ArticleId><ArticleId IdType="pubmed">26123042</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizzardo M, Simone C, Falcone M, Riboldi G, Rizzo F, Magri F, et al. Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis. Cell Mol Life Sci CMLS. 2012;69:1641&#x2013;1650. doi: 10.1007/s00018-011-0881-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-011-0881-5</ArticleId><ArticleId IdType="pubmed">22094924</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizzardo M, Simone C, Rizzo F, Ruggieri M, Salani S, Riboldi G, et al. Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model. Hum Mol Genet. 2014;23:342&#x2013;354. doi: 10.1093/hmg/ddt425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt425</ArticleId><ArticleId IdType="pmc">PMC3869354</ArticleId><ArticleId IdType="pubmed">24006477</ArticleId></ArticleIdList></Reference><Reference><Citation>Osen-Sand A, Catsicas M, Staple JK, Jones KA, Ayala G, Knowles J, et al. Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature. 1993;364:445&#x2013;448. doi: 10.1038/364445a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364445a0</ArticleId><ArticleId IdType="pubmed">8332215</ArticleId></ArticleIdList></Reference><Reference><Citation>Park GH, Maeno-Hikichi Y, Awano T, Landmesser LT, Monani UR. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. J Neurosci. 2010;30:12005&#x2013;12019. doi: 10.1523/JNEUROSCI.2208-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2208-10.2010</ArticleId><ArticleId IdType="pmc">PMC2944776</ArticleId><ArticleId IdType="pubmed">20826664</ArticleId></ArticleIdList></Reference><Reference><Citation>Picelli S, Bjorklund AK, Faridani OR, Sagasser S, Winberg G, Sandberg R. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat Methods. 2013;10:1096&#x2013;1098. doi: 10.1038/nmeth.2639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2639</ArticleId><ArticleId IdType="pubmed">24056875</ArticleId></ArticleIdList></Reference><Reference><Citation>Picelli S, Faridani OR, Bjorklund AK, Winberg G, Sagasser S, Sandberg R. Full-length RNA-seq from single cells using Smart-seq2. Nat Protoc. 2014;9:171&#x2013;181. doi: 10.1038/nprot.2014.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2014.006</ArticleId><ArticleId IdType="pubmed">24385147</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiner A, Medina L, Figueredo-Cardenas G, Anfinson S. Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS. Exp Neurol. 1995;131:239&#x2013;250. doi: 10.1016/0014-4886(95)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-4886(95)90046-2</ArticleId><ArticleId IdType="pubmed">7895823</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Warita H, Komori T, Murakami T, Abe K, Iwata M. Parvalbumin and calbindin D-28k immunoreactivity in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2006;1083:196&#x2013;203. doi: 10.1016/j.brainres.2006.01.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2006.01.129</ArticleId><ArticleId IdType="pubmed">16546142</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Cabuy E, Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci. 2009;12:627&#x2013;636. doi: 10.1038/nn.2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Roselli F, Singh K, Leptien K, Julien JP, Gros-Louis F, et al. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron. 2013;80:80&#x2013;96. doi: 10.1016/j.neuron.2013.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.027</ArticleId><ArticleId IdType="pubmed">24094105</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarrott JM, Herranz-Martin S, Alrafiah AR, Shaw PJ, Azzouz M. Current developments in gene therapy for amyotrophic lateral sclerosis. Expert Opin Biol Ther. 2015;15:935&#x2013;947. doi: 10.1517/14712598.2015.1044894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.2015.1044894</ArticleId><ArticleId IdType="pubmed">25959569</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder HD, Reske-Nielsen E. Preservation of the nucleus X-pelvic floor motosystem in amyotrophic lateral sclerosis. Clin Neuropathol. 1984;3:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">6499298</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw PJ, Tomkins J, Slade JY, Usher P, Curtis A, Bushby K, et al. CNS tissue Cu/Zn superoxide dismutase (SOD1) mutations in motor neurone disease (MND) NeuroReport. 1997;8:3923&#x2013;3927. doi: 10.1097/00001756-199712220-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199712220-00016</ArticleId><ArticleId IdType="pubmed">9462467</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon CM, Dai Y, Van Alstyne M, Koutsioumpa C, Pagiazitis JG, Chalif JI, et al. Converging mechanisms of p53 activation drive motor neuron degeneration in spinal muscular atrophy. Cell Rep. 2017;21:3767&#x2013;3780. doi: 10.1016/j.celrep.2017.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.12.003</ArticleId><ArticleId IdType="pmc">PMC5747328</ArticleId><ArticleId IdType="pubmed">29281826</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone C, Nizzardo M, Rizzo F, Ruggieri M, Riboldi G, Salani S, et al. iPSC-Derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1. Stem Cell Rep. 2014;3:297&#x2013;311. doi: 10.1016/j.stemcr.2014.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2014.06.004</ArticleId><ArticleId IdType="pmc">PMC4176534</ArticleId><ArticleId IdType="pubmed">25254343</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Ciriacono M, Manno C, La Bella V. The eye-tracking computer device for communication in amyotrophic lateral sclerosis. Acta Neurol Scand. 2014;130:40&#x2013;45. doi: 10.1111/ane.12214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12214</ArticleId><ArticleId IdType="pubmed">24350578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudhof TC. Synaptotagmins: why so many? J Biol Chem. 2002;277:7629&#x2013;7632. doi: 10.1074/jbc.R100052200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R100052200</ArticleId><ArticleId IdType="pubmed">11739399</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511&#x2013;515. doi: 10.1038/nbt.1621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1621</ArticleId><ArticleId IdType="pmc">PMC3146043</ArticleId><ArticleId IdType="pubmed">20436464</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L, Schwaller B, Vleminckx V, Meijers B, Stork S, Ruehlicke T, et al. Protective effect of parvalbumin on excitotoxic motor neuron death. Exp Neurol. 2002;174:150&#x2013;161. doi: 10.1006/exnr.2001.7858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2001.7858</ArticleId><ArticleId IdType="pubmed">11922657</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med. 2012;18:1418&#x2013;1422. doi: 10.1038/nm.2901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2901</ArticleId><ArticleId IdType="pubmed">22922411</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2008;31:395&#x2013;405. doi: 10.1016/j.nbd.2008.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.05.016</ArticleId><ArticleId IdType="pubmed">18586098</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. JMD. 2012;14:22&#x2013;29. doi: 10.1016/j.jmoldx.2011.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmoldx.2011.08.002</ArticleId><ArticleId IdType="pmc">PMC3338343</ArticleId><ArticleId IdType="pubmed">22166544</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>